Dr. Gail Tomlinson was recruited in 2007 to UT Health San Antonio to lead the Division of Pediatric Hematology-Oncology and currently serves as Interim Director of the Greehey Children’s Cancer Research Institute (Greehey CCRI). At the Greehey CCRI, she focuses on developing translational research studies aiming to bridge basic and clinical research.
She received her M.D. from George Washington University School of Medicine and her Ph.D. in Biochemistry from Duke University. She completed an internship and residency at the National Children’s Medical Center in Washington, D.C. She did a research fellowship in cancer genetics at the University of Texas M.D. Anderson Cancer Center in Houston, followed by a formal fellowship in pediatric hematology-oncology at the University of Texas Southwestern Medical Center in Dallas. She was a faculty member at the University of Texas Southwestern Medical Center from 1992 to 2006, where she held the Children’s Cancer Fund Distinguished Professorship in Pediatric Oncology Research. She currently is the holder of the Greehey Distinguished Chair in Cancer and Genetics.
Dr. Tomlinson is board certified in pediatrics and pediatric hematology-oncology. Her research interests are in the genetic origins of childhood cancers, particularly tumors of the liver. She also has initiated an investigation of predisposing factors underlying the increased incidence of leukemia in children of Hispanic background in South Texas.
She directs the national registry of children with tumors of the liver as well as a comprehensive genomics investigation of pediatric liver tumors funded by the Cancer Prevention and Research Institute of Texas. She has served on multiple national and state committees focusing on advancing research in childhood cancer and has published over 120 scientific papers.
Hill, D. A., Horick, N. K., Isaacs, C., Domchek, S. M., Tomlinson, G. E., Lowery, J. T., Kinney, A. Y., Berg, J. S., Edwards, K. L., Moorman, P. G., Plon, S. E., Strong, L. C., Ziogas, A., Griffin, C. A., Kasten, C. H. & Finkelstein, D. M. Long-term risk of medical conditions associated with breast cancer treatment. Breast Cancer Res. Treat. 145(1):233-43 (2014). PMID: 24696430; PMCID: PMC4096572
Hsiao ,T-H, Chen, H.H., Lu, J-Y, Lin, P-Y, Keller, C., Comerford, S., Tomlinson, G.E. & Chen Y. Utilizing Signature-score to Identify Oncogenic Pathways of Cholangiocarcinoma. Translational Cancer Research Vol 2, No 1 (2013). PMID: 23905013; PMCID: PMC3725832
King, E. E., Qin, Y., Toledo, R. A., Luo, A., Ball, E., Faucz, F. R., Janeway, K. A., Stratakis, C. A., Tomlinson, G. & Dahia, P. Integrity of the pheochromocytoma susceptibility TMEM127 gene in pediatric malignancies. Endocr. Relat. Cancer 22(3):L5-7 (2015). PMID: 25770152